v3.26.3
Net Loss Per Common Share (Tables)
9 Months Ended
Sep. 30, 2026
Earnings Per Share [Abstract]  
Schedule of Antidilutive Securities Excluded from Computation of Net Loss Per Common Share
A reconciliation of the numerator and denominator used in the calculation of basic and diluted net income (loss) per share is as follows (in thousands):
Three months ended September 30,Nine Months Ended September 30,
2026202520262025
Numerator (basic and diluted):
Net income (loss)$11,290 $621 $(17,577)$(10,527)
Denominator:
Weighted-average shares outstanding for basic net income (loss) per share180,941,748 163,649,932 174,800,967 158,559,467 
Effect of dilutive securities:
RSUs5,675,998 9,829,642 — — 
Stock Options1,746,477 2,041,961 — — 
Warrants79,307 2,095,772 — — 
Convertible Notes1,480,502 — — — 
Weighted-average shares outstanding for diluted net income (loss) per share189,924,032 177,617,307 174,800,967 158,559,467 
The following potentially dilutive securities were excluded from the computation of diluted weighted average common shares outstanding due to their anti-dilutive effect:
Three months ended September 30,Nine Months Ended September 30,
2026202520262025
Shares to be issued upon conversion of Convertible Notes— 10,971,895 — 10,971,895
RSUs— — 9,245,814 13,776,105 
Stock Options— — 6,925,293 5,765,600 
Warrants— — 125,999 2,664,470 
Total anti-dilutive securities excluded from EPS computation— 10,971,895 16,297,106 33,178,070